Dyne Therapeutics Inc (DYN)vsInsmed Inc (INSM)
DYN
Dyne Therapeutics Inc
$18.98
+6.33%
HEALTHCARE · Cap: $3.13B
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
DYN leads profitability with a 0.0% profit margin vs -2.1%. DYN appears more attractively valued with a PEG of 0.19. DYN earns a higher WallStSmart Score of 40/100 (F).
DYN
Hold40
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Growing faster than its price suggests
No standout strengths identified
Areas to Watch
0.0% revenue growth
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DYN
The strongest argument for DYN centers on PEG Ratio. PEG of 0.19 suggests the stock is reasonably priced for its growth.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : DYN
The primary concerns for DYN are Revenue Growth, EPS Growth, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
DYN profiles as a value stock while INSM is a turnaround play — different risk/reward profiles.
DYN carries more volatility with a beta of 1.40 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
DYN generates stronger free cash flow (-112M), providing more financial flexibility.
Bottom Line
DYN scores higher overall (40/100 vs 39/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Dyne Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?